{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T13:15:28Z","timestamp":1785503728240,"version":"3.56.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T00:00:00Z","timestamp":1758844800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-15187-2","type":"journal-article","created":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:01:21Z","timestamp":1758884481000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Refinement of the rat acetylcholine receptor-specific passive transfer myasthenia gravis model using subcutaneous injections: an update to the guidelines"],"prefix":"10.1038","volume":"15","author":[{"given":"Britt","family":"Arets","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Man\u00e9-Damas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja K.","family":"Sch\u00f6ttler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia M.","family":"Sikorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda L.","family":"Kusner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry J.","family":"Kaminski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Losen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Martinez-Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,26]]},"reference":[{"key":"15187_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.expneurol.2015.02.025","volume":"270","author":"LL Kusner","year":"2015","unstructured":"Kusner, L. L. et al. Guidelines for pre-clinical assessment of the acetylcholine receptor-specific passive transfer myasthenia Gravis model\u2014Recommendations for methods and experimental designs. Exp. Neurol. 270, 3\u201310 (2015).","journal-title":"Exp. Neurol."},{"key":"15187_CR2","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1056\/NEJM197701202960301","volume":"296","author":"KV Toyka","year":"1977","unstructured":"Toyka, K. V. et al. Myasthenia Gravis. N. Engl. J. Med. 296, 125\u2013131 (1977).","journal-title":"N. Engl. J. Med."},{"key":"15187_CR3","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1126\/science.1179220","volume":"190","author":"KV Toyka","year":"1979","unstructured":"Toyka, K. V., Brachman, D. B., Pestronk, A. & Kao, I. Myasthenia gravis: passive transfer from man to mouse. Science 190, 397\u2013399 (1979).","journal-title":"Science"},{"key":"15187_CR4","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/285238a0","volume":"285","author":"VA Lennon","year":"1980","unstructured":"Lennon, V. A. & Lambert, E. H. Myasthenia Gravis induced by monoclonal antibodies to acetylcholine receptors. Nature 285, 238\u2013240 (1980).","journal-title":"Nature"},{"key":"15187_CR5","doi-asserted-by":"publisher","first-page":"8635","DOI":"10.1016\/S0021-9258(19)68891-5","volume":"256","author":"SJ Tzartos","year":"1981","unstructured":"Tzartos, S. J., Rand, D. E., Einarson, B. L. & Lindstrom, J. M. Mapping of surface structures of electrophorus acetylcholine receptor using monoclonal antibodies. J. Biol. Chem. 256, 8635\u20138645 (1981).","journal-title":"J. Biol. Chem."},{"key":"15187_CR6","doi-asserted-by":"publisher","first-page":"2899","DOI":"10.1073\/pnas.85.9.2899","volume":"85","author":"SJ Tzartos","year":"1988","unstructured":"Tzartos, S. J., Kokla, A., Walgrave, S. L. & Conti-Tronconi, B. M. Localization of the main Immunogenic region of human muscle acetylcholine receptor to residues 67\u201376 of the alpha subunit. Proc. Natl. Acad. Sci. 85, 2899\u20132903 (1988).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"15187_CR7","doi-asserted-by":"publisher","first-page":"103104","DOI":"10.1016\/j.autrev.2022.103104","volume":"21","author":"M Man\u00e9-Damas","year":"2022","unstructured":"Man\u00e9-Damas, M. et al. Novel treatment strategies for acetylcholine receptor antibody-positive myasthenia Gravis and related disorders. Autoimmun. Rev. 21, 103104 (2022).","journal-title":"Autoimmun. Rev."},{"key":"15187_CR8","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.omtm.2019.04.009","volume":"13","author":"LL Kusner","year":"2019","unstructured":"Kusner, L. L. et al. Investigational RNAi therapeutic targeting C5 is efficacious in Pre-clinical models of myasthenia Gravis. Mol. Ther. Methods Clin. Dev. 13, 484\u2013492 (2019).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"15187_CR9","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1038\/s41598-017-01019-5","volume":"7","author":"M Losen","year":"2017","unstructured":"Losen, M. et al. Hinge-deleted IgG4 blocker therapy for acetylcholine receptor myasthenia Gravis in rhesus monkeys. Sci. Rep. 7, 992 (2017).","journal-title":"Sci. Rep."},{"key":"15187_CR10","first-page":"1554","volume":"317","author":"N van der Kolfschoten","year":"2007","unstructured":"van der Kolfschoten, N. Anti-Inflammatory activity of human IgG4 antibodies by dynamic fab arm exchange. Science. 317, 1554\u20131557 (2007).","journal-title":"Sci. (1979)"},{"key":"15187_CR11","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1002\/ana.21536","volume":"65","author":"J Soltys","year":"2009","unstructured":"Soltys, J. et al. Novel complement inhibitor limits severity of experimentally myasthenia Gravis. Ann. Neurol. 65, 67\u201375 (2009).","journal-title":"Ann. Neurol."},{"key":"15187_CR12","doi-asserted-by":"crossref","unstructured":"Song, J. et al. A targeted complement inhibitor crig\/fh protects against experimental autoimmune myasthenia Gravis in rats via immune modulation. Front. Immunol. 13 (2022).","DOI":"10.3389\/fimmu.2022.746068"},{"key":"15187_CR13","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.4049\/jimmunol.179.12.8562","volume":"179","author":"Y Zhou","year":"2007","unstructured":"Zhou, Y. et al. Anti-C5 antibody treatment ameliorates weakness in experimentally acquired myasthenia Gravis. J. Immunol. 179, 8562\u20138567 (2007).","journal-title":"J. Immunol."},{"key":"15187_CR14","doi-asserted-by":"publisher","unstructured":"Nebendahl, K. Chapter 24\u2014Routes of administration. In The Laboratory Rat (ed Krinke, G. J.) 463\u2013483. https:\/\/doi.org\/10.1016\/B978-012426400-7.50063-7 (Academic, 2000).","DOI":"10.1016\/B978-012426400-7.50063-7"},{"key":"15187_CR15","first-page":"600","volume":"50","author":"PV Turner","year":"2011","unstructured":"Turner, P. V., Brabb, T., Pekow, C. & Vasbinder, M. A. Administration of substances to laboratory animals: routes of administration and factors to consider. J. Am. Assoc. Lab. Anim. Sci. 50, 600\u2013613 (2011).","journal-title":"J. Am. Assoc. Lab. Anim. Sci."},{"key":"15187_CR16","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1128\/am.16.9.1418-1419.1968","volume":"16","author":"JP Steward","year":"1968","unstructured":"Steward, J. P., Ornellas, E. P., Beernink, K. D. & Northway, W. H. Errors in the technique of intraperitoneal injection of mice. Appl. Microbiol. 16, 1418\u20131419 (1968).","journal-title":"Appl. Microbiol."},{"key":"15187_CR17","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1128\/am.19.4.704-705.1970","volume":"19","author":"V Arioli","year":"1970","unstructured":"Arioli, V. & Rossi, E. Errors related to different techniques of intraperitoneal injection in mice. Appl. Microbiol. 19, 704\u2013705 (1970).","journal-title":"Appl. Microbiol."},{"key":"15187_CR18","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1258\/002367707781282802","volume":"41","author":"R Gaines Das","year":"2007","unstructured":"Gaines Das, R. & North, D. Implications of experimental technique for analysis and interpretation of data from animal experiments: outliers and increased variability resulting from failure of intraperitoneal injection procedures. Lab. Anim. 41, 312\u2013320 (2007).","journal-title":"Lab. Anim."},{"key":"15187_CR19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1258\/002367799780578543","volume":"33","author":"W D\u00f6rr","year":"1999","unstructured":"D\u00f6rr, W. & Weber-Frisch, M. Short-term immobilization of mice by methohexitone. Lab. Anim. 33, 35\u201340 (1999).","journal-title":"Lab. Anim."},{"key":"15187_CR20","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000524587","volume":"15","author":"G Olesen","year":"2023","unstructured":"Olesen, G. Development, characterization, and in vivo validation of a humanized C6 monoclonal antibody that inhibits the membrane attack complex. J. Innate Immun. 15, 16\u201336 (2023).","journal-title":"J. Innate Immun."},{"key":"15187_CR21","doi-asserted-by":"crossref","unstructured":"Lekova, E. et al. Discovery of functionally distinct anti-C7 monoclonal antibodies and stratification of anti-nicotinic achr positive myasthenia Gravis patients. Front. Immunol. 13 (2022).","DOI":"10.3389\/fimmu.2022.968206"},{"key":"15187_CR22","first-page":"3434","volume":"51","author":"JS Barrett","year":"1991","unstructured":"Barrett, J. S., Wagner, J. G., Fisher, S. J. & Wahl, R. L. Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat. Cancer Res. 51, 3434\u20133444 (1991).","journal-title":"Cancer Res."},{"key":"15187_CR23","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1182\/blood-2008-07-168146","volume":"113","author":"DM Goldenberg","year":"2009","unstructured":"Goldenberg, D. M. et al. Properties and structure-function relationships of veltuzumab (hA20), a humanized anti-CD20 monoclonal antibody. Blood 113, 1062\u20131070 (2009).","journal-title":"Blood"},{"key":"15187_CR24","doi-asserted-by":"publisher","first-page":"2327","DOI":"10.1093\/brain\/awh612","volume":"128","author":"M Losen","year":"2005","unstructured":"Losen, M. et al. Increased expression of Rapsyn in muscles prevents acetylcholine receptor loss in experimental autoimmune myasthenia Gravis. Brain 128, 2327\u20132337 (2005).","journal-title":"Brain"},{"key":"15187_CR25","doi-asserted-by":"publisher","first-page":"e0238123","DOI":"10.1371\/journal.pone.0238123","volume":"15","author":"JN Reimer","year":"2020","unstructured":"Reimer, J. N., Schuster, C. J., Knight, C. G., Pang, D. S. J. & Leung, V. S. Y. Intraperitoneal injection of sodium pentobarbital has the potential to elicit pain in adult rats (Rattus norvegicus). PLoS One. 15, e0238123 (2020).","journal-title":"PLoS One"},{"key":"15187_CR26","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/0022-1759(88)90218-9","volume":"107","author":"A Quinn","year":"1988","unstructured":"Quinn, A., Harrison, R., Jehanli, A. M. T., Lunt, G. G. & Walsh, S. An ELISA for the detection of anti-acetylcholine receptor antibodies using biotinylated \u03b1-bungarotoxin. J. Immunol. Methods. 107, 197\u2013203 (1988).","journal-title":"J. Immunol. Methods"},{"key":"15187_CR27","doi-asserted-by":"crossref","unstructured":"You, A. et al. Development of a refined experimental mouse model of myasthenia Gravis with anti-acetylcholine receptor antibodies. Front. Immunol. 16 (2025).","DOI":"10.3389\/fimmu.2025.1521382"},{"key":"15187_CR28","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.ajpath.2016.05.025","volume":"186","author":"AM Gomez","year":"2016","unstructured":"Gomez, A. M. et al. Silencing of Dok-7 in adult rat muscle increases susceptibility to passive transfer myasthenia Gravis. Am. J. Pathol. 186, 2559\u20132568 (2016).","journal-title":"Am. J. Pathol."},{"key":"15187_CR29","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.expneurol.2015.03.010","volume":"270","author":"M Losen","year":"2015","unstructured":"Losen, M. et al. Standardization of the experimental autoimmune myasthenia Gravis (EAMG) model by immunization of rats with torpedo Californica acetylcholine receptors \u2014 Recommendations for methods and experimental designs. Exp. Neurol. 270, 18\u201328 (2015).","journal-title":"Exp. Neurol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15187-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15187-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15187-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T11:01:22Z","timestamp":1758884482000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-15187-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,26]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15187"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-15187-2","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-6113927\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,26]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33062"}}